(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 7. Functional Wnt8 is not required for late expression of neural crest
markers. Whole-mount in-situ hybridization for neural crest marker,
sox10, on 10-somite (A,B) and 24hpf (C,D) stage embryos. (E,F)
Whole-mount in-situ hybridization for melanophore-specific marker,
mitfa. (G,H) Whole-mount in-situ hybridization for cranial neural
crest marker, dlx2. Injection of 20 mg/ml wnt8.1 antisense Morpholino
oligonucleotides does not significantly reduce or eliminate the expression of
any of these neural crest markers. All images of uninjected control siblings
(A,C,E,G) and wnt8.1 MO-injected embryos (B,D,F,H) are lateral views (B-F) or
dorsal views (A-B,G-H) with anterior to the left. Scale bar: 100 µm in
(A,B); 200 µm in (C-F); 50 µm in (G,H).